Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Active Pharmaceutical Ingredients Market 2016 Share, Trend, Segmentation And Forecast To 2020

Thursday, February 23, 2017 23:36
% of readers think this story is Fact. Add your two cents.

(Before It's News)

The analysts forecast the global active pharmaceutical ingredients market to grow at a CAGR of 6.61% during the period 2017-2021.

A drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological methods.

Download Sample Report @ https://marketreportscenter.com/request-sample/490843

Covered in this report

The report covers the present scenario and the growth prospects of the global active pharmaceutical ingredients market for 2017-2021. To calculate the market size, the report considers the sales of APIs in key applications areas of the pharmaceutical industry. The report considers the revenue generated from the sales of cardiovascular drugs, diabetes drugs, central nervous system (CNS) drugs, oncology drugs, and others.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

The report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Aurobindo Pharma
• Cipla
• Dr. Reddy’s Laboratories
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries

 

To Get More Details Of The Report: https://marketreportscenter.com/reports/490843/global-ablation-systems-market-research-report-2017

Other prominent vendors
• Abbott Laboratories
• Albemarle
• Amgen
• BASF
• Biocon
• Boehringer Ingelheim
• Bristol-Myers Squibb
• CIRON Drugs & Pharmaceuticals
• Dishman Pharmaceuticals and Chemicals
• Emcure Pharmaceuticals
• Ipca Laboratories
• Johnson Matthey
• Guilin Pharmaceutical
• Johnson & Johnson
• Lonza Group
• Merck
• Novartis
• Pfizer
• Roche

Market driver
• Strong focus on HPAPI
• For a full, detailed list, view our report

Market challenge
• Government regulations
• For a full, detailed list, view our report

Market trend
• Growing influence of key markets
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

 Table of Contents

PART 01: Executive summary 

PART 02: Scope of the report
• Market overview

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Overview

PART 05: Market landscape
• Global APIs market
• Five forces analysis

PART 06: Market segmentation by production process
• Global APIs market by production process
• Global synthetic APIs market
• Global biotech APIs market

PART 07: Market segmentation by type
• Global APIs market by type

PART 08: Market segmentation by vendor type
• Global APIs market by vendor type
• Global captive APIs market
• Global merchant APIs market

PART 09: Geographic segmentation
• Global APIs market by geography
• APIs market in Americas
• APIs market in APAC
• APIs market in EMEA
• Global APIs market by therapeutic areas

PART 10: Market drivers
• Increasing incidence of age-related diseases globally
• Strong focus on HPAPI
• Measures against counterfeit drugs

PART 11: Impact of drivers 

PART 12: Market challenges
• Government regulations
• Fierce competition among API manufacturers
• Less R&D spending
• Availability of counterfeit products

PART 13: Impact of drivers and challenges 

PART 14: Market trends
• Growing influence of key markets
• Emergence of Africa
• Increasing outsourcing activities

..…..Continued

Check Discount On This Report @ https://marketreportscenter.com/request-discount/490843

For more information, please visit https://marketreportscenter.com

For more information content with us;

Sam Collins

Market Reports Center 1-646-883-3044 (US)

info@marketreportscenter.com

https://marketreportscenter.com

Source: https://marketreportscenter.com/reports/490843/global-ablation-systems-market-research-report-2017

 

 

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.